MedTrace Logo

Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management

NCT02485795 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2017-06-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of genetic testing on healthcare decisions and patient outcomes in interventional pain management clinical care. Results of genetic testing will also be compared with the clinical outcome measures collected to discover novel genetic factors that may influence patient care.

Conditions

Interventions

OTHER

Observational

This study will evaluate the impact of genetic testing information on medical regimen plans and whether this information results in benefits to patient care.

Sponsors & Collaborators

  • Proove Bioscience, Inc.

    lead INDUSTRY

Principal Investigators

  • Maneesh Sharma, M.D. · Interventional Pain Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-06-30
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02485795 on ClinicalTrials.gov